Erik Lium
Director/Board Member bij RENALYTIX PLC
Actieve functies van Erik Lium
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RENALYTIX PLC | Director/Board Member | 01-11-2018 | - |
Independent Dir/Board Member | 01-11-2018 | - | |
VERICI DX PLC | Director/Board Member | 19-08-2020 | - |
TRELLUS HEALTH PLC | Director/Board Member | - | - |
ELWC Enterprises Ltd. | Director/Board Member | - | - |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Director/Board Member | - | - |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Private Equity Investor | 01-04-2017 | - |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | Director/Board Member | - | - |
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Private Equity Investor | 01-07-2019 | - |
Corporate Officer/Principal | 01-07-2019 | - | |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Chairman | - | - |
Director/Board Member | - | - | |
░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - | - |
Loopbaan van Erik Lium
Eerdere bekende functies van Erik Lium
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Erik Lium
Gonzaga University | Undergraduate Degree |
Columbia University College of Physicians & Surgeons | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 14 |
Verenigd Koninkrijk | 5 |
Operationeel
Director/Board Member | 10 |
Private Equity Investor | 3 |
Corporate Officer/Principal | 2 |
Sectoraal
Technology Services | 5 |
Consumer Services | 5 |
Finance | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
RENALYTIX PLC | Technology Services |
VERICI DX PLC | Health Services |
TRELLUS HEALTH PLC | Technology Services |
Bedrijven in privébezit | 10 |
---|---|
LabVelocity
LabVelocity Packaged SoftwareTechnology Services Part of Copyright Clearance Center, Inc., LabVelocity develops scientific software solutions. The private company is based in Burlingame, CA. The company was founded by Erik Lium. LabVelocity was acquired by Infotrieve, Inc., part of Copyright Clearance Center, Inc. from November 06, 2014 on October 11, 2004. | Technology Services |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Finance |
Mount Sinai Ambulatory Ventures, Inc
Mount Sinai Ambulatory Ventures, Inc Investment ManagersFinance Mount Sinai Ambulatory Ventures, Inc (Mount Sinai Ambulatory Ventures) is a venture capital subsidiary of The Mount Sinai Health System, Inc founded in 2008. The firm is headquartered in New York. | Finance |
Amathus Therapeutics, Inc.
Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Finance |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Health Technology |
Mount Sinai Innovation Partners
Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. | Commercial Services |
ELWC Enterprises Ltd. | |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | Technology Services |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Health Technology |
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Health Services |